KLC
BVS icon

Kent Lake Capital’s Bioventus BVS Stock Holding History

Kent Lake Capital’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-532,880
Closed -$2.81M – 46
2023
Q4 		$2.81M Sell
532,880
-502,288
-49% -$1.99M 1.08% 33
2023
Q3 		$3.42M Buy
1,035,168
+135,168
+15% +$474K 1.31% 29
2023
Q2 		$2.6M Buy
900,000
+513,051
+133% +$985K 1.2% 29
2023
Q1 		$414K Sell
386,949
-360,838
-48% -$690K 0.28% 32
2022
Q4 		$1.95M Buy
+747,787
New +$3.27M 1.17% 24

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Kent Lake Capital's BVS Position: Q1 2024 in Review

Kent Lake Capital sold out of Bioventus (BVS) in Q1 2024, closing a stake of 532,880 shares — an estimated $2.81M sold.

Kent Lake Capital first reported a position in BVS in Q4 2022 and held it in 5 quarters. The position peaked at $3.42M in Q3 2023. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

  • Kent Lake Capital reported no remaining Bioventus position as of Q1 2024 after selling out during the quarter.
  • Kent Lake Capital sold 532,880 Bioventus shares in Q1 2024, an estimated $2.81M.
  • Kent Lake Capital first reported a position in Bioventus in Q4 2022 and held it in 5 quarters.
  • Kent Lake Capital's Bioventus position peaked at $3.42M in Q3 2023.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on Kent Lake Capital's 13F filing for Q1 2024, filed 15 May 2024.